Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005Source: DataRank Database

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy is a research paper published in Clinical Genitourinary Cancer (2022). On theSindex it has a DataRank of 0.937. It has been cited 33 times, with 21 citing works in its 1-hop citation network.

N/A

0.937DataRank · unranked

Scored on demand from live citation data

Open Access33 citations · 21 citing works in its network

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: greenTopics (37)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 56%Citation Network 44%

Base Score Contribution

0.529

From this paper's citation signal

Citation Network Contribution

0.408

From 14 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 21 citers.

Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder
ESMO Open20247 citations14 referencesContributes 0.149
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
Clinical Genitourinary Cancer20244 citations33 referencesContributes 0.049
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract
Cancer Medicine20252 citations23 referencesContributes 0.048
Multidisciplinary treatment for small cell carcinoma of the bladder: a case report
International Cancer Conference Journal20241 citations15 referencesContributes 0.046
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
Urologic Oncology Seminars and Original Investigations20252 citations28 referencesContributes 0.039

Authors (30)

Brendan J. Guercio ORCID,Arshi Arora ORCID,Xueli Hao,Ashley Marie Regazzi ORCID,Timothy F. Donahue ORCID

Live enrichment

PubMed:35676169 PMC:PMC9809986

NCI

Grant: R01 CA233899

NCI

Grant: P30 CA008748

NCI

Grant: P50CA221745

NCI

Grant: K12 CA184746

Cycle for Survival

Grant: T32-CA009207

NCI NIH HHS

Grant: P01 CA221757

NCI NIH HHS

Grant: T32 CA009207

National Institutes of Health

Grant: 5T32CA009207-43

Investigational Cancer Therapeutics Training Program

National Institutes of Health

Grant: 1R01CA233899-01A1

Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

National Institutes of Health

Grant: 5K12CA184746-02

MSK Paul Calabresi Career Development Award for Clinical Oncology

National Institutes of Health

Grant: 5P01CA221757-02

Modeling bladder cancer pathogenesis and tumor evolution

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 1P50CA221745-01A1

SPORE in Bladder Cancer

Breast Cancer Research Foundation

National Institutes of Health

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9809986

publisherhttps://api.elsevier.com/content/article/PII:S1558767322001100?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1558767322001100?httpAccept=text/plain

https://doi.org/10.1016/j.clgc.2022.05.005

https://pubmed.ncbi.nlm.nih.gov/35676169

Fields of Study

03 medical and health sciences0302 clinical medicineCarcinoma, Small CellChemotherapy, AdjuvantCystectomyGenomicsHumansNeoadjuvant TherapyRetrospective StudiesUrinary BladderUrinary Bladder NeoplasmsXeroderma Pigmentosum Group D Protein

MeSH Terms

HumansCarcinoma, Small CellChemotherapy, AdjuvantNeoadjuvant TherapyCystectomyRetrospective StudiesGenomicsXeroderma Pigmentosum Group D ProteinUrinary BladderUrinary Bladder Neoplasms

Keywords

Bladder cancerUrothelial CarcinomaNeuroendocrine CarcinomaRadical CystectomySmall Cell Bladder CancerUrinary Bladder NeoplasmsChemotherapy, AdjuvantUrinary BladderHumansGenomicsCarcinoma, Small CellCystectomyNeoadjuvant TherapyRetrospective StudiesXeroderma Pigmentosum Group D Protein

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (2)

Cells of origin of lung cancers: lessons from mouse studies

N/A

5.6DataRank · unranked

Genes & Development(2020)

co-cited

10.1101/gad.338228.120

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

N/A

0.646DataRank · unranked

Modern Pathology(2024)

co-cited

10.1016/j.modpat.2024.100557

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (30)

Funding (15 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)